Category Science and Technology

Gene Editing: Where Should We Draw the Line?

Françoise Baylis continues to advocate for broad societal consensus on the future of germline genome editing and sees the Parliamentary Assembly of the Council of Europe as an ally given their support of broad public engagement.

Psychedelics, Doing Science, and Policing History

Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.

Canada’s Prohibition on Altering the Human Genome

Françoise Baylis and Alana Cattapan defend the current prohibition in Canada on making genetic alterations that can be passed on to future generations.

CAR-T cells: A drive to the future of cancer treatment

Conrad Fernandez describes the ethical challenges related to the use of CAR T-cell therapy for cancer patients.

Cyber Security & Implanted Bio-Monitoring Devices

Dylan Roskams Edris describes risks associated with implantable remote bio-monitoring devices.

Human genome editing: We should all have a say

Françoise Baylis stresses that decisions about the modification of the human germline should not be made without broad societal consultation.

Access to Physicians’ Prescription Habits

Jean-Christophe Bélisle-Pipon calls attention to issues of accessibility and transparency related to the collection and sale of physician prescribing data by data solution companies.